New rapidly acting insulin launched

Lyumjev is a new 'ultra rapidly acting' formulation of insulin lispro.

by Chloe Harman
No dose conversion is required if transferring a patient between strengths of Lyumjev. | IMAGE CREDIT: ELI LILLY
No dose conversion is required if transferring a patient between strengths of Lyumjev. | IMAGE CREDIT: ELI LILLY

Sign in to continue

Sign In

Trouble signing in?

Reset password: Click here

Need help? Email us

Register

FREE

  • Limited free articles a month 
  • Free email bulletins

Register Now

Subscribe now

Benefits include:

  • Full site access
  • Subscriber exclusive content
  • Exclusive bulletins

Choose a package